• Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Bulgaria Czechia France Germany Greece Hungary +4
  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Austria Finland France Germany Ireland Italy +6
  • Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Greece The Netherlands Portugal Romania
  • Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany Hungary Italy
  • Study on the Effectiveness and Safety of Trastuzumab, Tucatinib, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study Comparing Injection Therapy with Triamcinolone Acetonide and Triamcinolone Hexacetonide to Surgery for Carpal Tunnel Syndrome in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Norway
  • Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Denmark France Germany Italy Spain
  • Study on the Safety and Feasibility of Diamyd (Glutamate Decarboxylase 2) for Individuals Aged 8-17 at Risk for Type 1 Diabetes with HLA DR3-DQ2 Haplotype

    Not recruiting

    2 1 1
    Investigated Diseases:
    Sweden
  • Study on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Germany Italy Spain
  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

powered by